Genetic polymorphism in critically-ill patients: Special applications of genetic polymorphisms. Pharmacogenetic and gene therapy;Polimorfismo genético en el paciente crítico. Parte II: Aplicaciones especiales de los polimorfismos genéticos. Farmacogenética y terapia génica

Medicina Intensiva

Volumn 27, Issue 3, 2003, Pages 181-187

  Sirgo, G ^a   Rello, J ^b   Bodi M ^b   Diaz, E ^b   Perez Vela J L ^a   Hernandez G ^a   Waterer, G ^c  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Acute respiratory; Cardiac surgery; Coagulation; Distress syndrome; Gene therapy; Genetic polymorphism; Pharmacogenetics; Trauma

Indexed keywords

DNA;

BLOOD CLOTTING; CARDIOVASCULAR SURGERY; CRITICAL ILLNESS; GENE DISRUPTION; GENE THERAPY; GENETIC IDENTIFICATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOME; HIGH RISK PATIENT; HUMAN; INJURY; MARKER GENE; PATHOPHYSIOLOGY; PHARMACOGENETICS; RESPIRATORY DISTRESS; REVIEW; RISK ASSESSMENT; SURGICAL PATIENT; TREATMENT OUTCOME;

EID: 0037363975     PISSN: 02105691     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0210-5691(03)79890-8     Document Type: Review

References (48)

1. Menges T, Hermans PW, Little SG, Langefeld T, Boning O, Engel J. Plasminogen-activator-inhibitor-1 4G/5G promoter polymorphism and prognosis of severely injured patients. Lancet 2001;357:1096-7.
2. Dahlback B, Carlsson M, Svensson PJ. Familiar thrombophilia due to a previously unrecognised mechanism characterized by poor anticoagulant response to activated protein C. Proc Natl Acad Sci USA 1993;90:1004-8.
3. Hoerl HD, Tabares A, Kottke-Marchant K. The diagnosis and clin:ical manifestations of activated protein C resistance: a case report and review of the literature. Vasc Med 1996;106:588-93.
4. Roberts GW, Gentleman SM, Lynch A, Murray L, Landon M, Graham DI, et al. P-amyloid protein deposition in the brain after severe head injury: implications for the pathogenesis of Alzheimer's disease. J Neurol Neurosurg Psychiatry 1994;57:419-25.
5. Nicoll JAR, Roberts GW, Graham DI. Apolipoprotein E epsilon 4 allele is associated with deposition of amyloid beta-protein following head injury. Nature Med 1995;1:135-7.
6. Liaquat I, Dunn LT, Nicoll JA, Teasdale GM, Norrie JD. Effect of apolipoprotein E genotype on hematoma volume after trauma. J Neurosurg 2002;96:90-6.
7. Sorbi S, Nacmias N, Piacentini Repice A, Latorraca S, Forleo P. ApoE as a prognostic factor post-traumatic coma. Nature Med 1995;1:852.
8. Teasdale GM, Nicoll JA, Murray G, Fidess M. Association od apolipoprotein E polymorphism with outcome after head injury. Lancet 1997;350:1069-71.
9. Roses AD, Saunders A. Head injury, amyloid beta and Alzheimer's disease. Nature Med 1995;1:603-4.
10. Iwata N, Tsubuki S, Takaki Y, Watanabe K, Sekiguchi M, Hosoki E. Identification of the major Abeta1-42-degrading catabolic pathway in brain parenchyma: supression leads to biochemical and pathological deposition. Nat Med 2000;6:143-50.
11. Scheifermeier M, Kollegger H, Madl C, Schward C, Holzer M, Kofler HJ. Apolipoprotein E polimorphism. Survival and neurological outcome after cardiopulmonary resuscitation. Stroke 2000;31:2068-73.
12. Armstrong L, Millar AB. Relative production of tumour necrosis factor α and interleukin 10 in adult respiratory distress syndrome. Thorax 1997;52:442-6.
13. Lin Z, Pearson C, Chinchilli V, Pietschmann SM, Luo J, Pison U. Polymorphisms of human SP-A, SP-B and SP-D genes: asociation of SP-B Thr13Ile with ARDS. Clin Genet 2000;58: 181-91.
14. Rigat B, Hubert C, Albenc-Gelas F, Cambien F, Corvol P, Soubrien F. An insertion/deletion polymorphism in the angiotensin 1-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990;86:1343-6.
15. Montgomery H, Marshall R, Hemingway H, Myerson S, Clarkson P, Dollery C. Human gene for physical perfomance. Nature 1998;393:221.
16. Marshall RP, Webb S, Hill MR, Humphries SE, Laurent GJ. Genetic polymorphisms associated with susceptibility and outcome in ARDS. Chest 2002;121(3Suppl):S68-9.
17. Stüber F, Andreas H. The influence of genomics on outcome after cardiovascular surgery. Curr Opin Anaesthesiol 2002; 15:3-8.
18. Kim HS, Lee MM, Oh BH, Kim KI, Han KH, Park SK. Synergistic effect of angiotensin-converting enzyme and angiotensinogen gene on cardiac hypertrophy. Int J Cardiol 2000;2: 151-61.
19. Densem CG, Hutchinson IV, Cooper A, Yonan N, Brooks NH. Polymorphism of the transforming growth factor-beta 1 gene correlates with the development of coronary vasculopathy following cardiac transplantation. J Heart Lung Transplant 2000;6:51-6.
20. Pethig K, Heublein B, Hoffmann A, Borlak J, Wahlers T, Haverich A. ACE-gene polymorphism is associated with the development of allograft vascular disease in heart transplant recipients. J Heart Lung Transplant 2000;12:1175-82.
21. Mathew JP, Rinder CS, Howe JG, Fontes M, Crouch J, Newman NF. Platelet PIA2 polymorphism enhances risk of neurocognitive decline after cardiopulmonary bypass. Multicenter Study of Perioperative ischemia (McSPI) Research Group. Ann Thorac Surg 2001;2:663-6.
22. Martínez F, Prieto D, Iribarren JL, Salido E, Torres A. Predisposición genética al síndrome de bajo gasto cardíaco tras la revascularización miocárdica con recirculación extracorporea. Med Intensiva 2002;26:153.
23. Ridker PM, Hennekens CH, Buring J, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000;342:836-43.
24. Biasucci LM, Liuzzo G, Fantuzzi G, Caligiuri G, Rebuzzi AG, Ginnetti. F. Increasing levels of interleukin (IL)-IRa and IL-6 during the first 2 days of hospitalization in unstable angina are associated with increased risk of in-hospital coronary events. Circulatin 1999;99:2079-84.
25. Biasucci LM, Vitelli A, Liuzzo G, Altamura S, Caligiuri G, Monaco C. Elevated levels of interleukin-6 in unstable angina. Circulation 1996;94:874-7.
26. Brull DJ, Montgomery HE, Sanders S, Dhamrait S, Luong L, Rumley A. Interleukin-6 gene -174G> and -572G>C promoter polymorphism are strong predictors of plasma interleukin-6 levels after coronary artery bypass surgery. Arterioscler Thromb Vasc Biol 2001;21:1458-63.
27. Borozdenkova S, Smith J, Marshall S, Yacoub M, Rose M. Identification of ICAM-1 polymorphism that is associated with protection from transplant associatiated vasculopathy after cardiac transplantation. Hum Immunol 2001;3:247-55.
28. Philip I, Plantefeve G, Vuilaumier-Barrot S, Vicaut E, Le Marie C, Henrion D. G894T polymorphism in the endothelial nitric oxide synthase gene is associated with an enhanced vascular responsiveness to phenylephrine. Circulation 1999;24:3096-8.
29. Chew ST, Newman MF, White D, Conlon PJ, Saunders AM, Strittmatter WJ. Preliminary report on the association of apolipoprotein E polymorphisms with postoperative peak serum creatinine concentrations in cardiac surgical patients. Anesthesiology 2000;2:325-31.
30. Tardiff BE, Newman MF, Saunders AM, Strittmatter WJ, Blumenthal JA, White WD. Preliminary report of genetic basis for cognitive decline after cardiac operations. The Neurologic Outcome Research Group of the Duke Heart Center. Ann Thorac Surg 1997;3:715-20.
31. Kalow W. Pharmacogenetics in biological perspective. Pharmacol Rev 1997;49:369-79.
32. Evans WE, Relling MV. Pharmacogenomics: translating functional genomics into rational therapeutics. Science 1999;286: 487-91.
33. Abernethy DR, Flockhart DA. Molecular basis of cardiovascular drug metabolism implications for predicting clinical important drug interactions. Circulation 2000;101:1749-53.
34. Santis G, Evans TW. Molecular biology for the critical care physician. Part II. Where are we now? Crit Care Med 1999;27:997-1003.
35. Beck JM, Liggit HD, Brunette EN. Reduction in intensity of pneumocystis carinii pneumonia in mice by aerosol administration of interferon-gamma. Infect Immunol 1991;59:3859-62.
36. Koll JK, Ye P, Shellito J. Gene therapy to modify pulmonary hosto defenses. Semin Respir Infect 1999;14:94-102.
37. Chehimi J, Trinchieri G. Interleukin-12: a bridge between innate resistance and adaptative immunity with a role in infección and adquired immunodeficiency. J Clin Immunol 1994;14: 149-61.
38. Greenberger MJ, Kunkel SL, Strieter RM. IL-12 gene therapy protecs mice in lethal Klebsiella pneumonia. J Immunol 1996;157:3006-12.
39. Bonavida B. Immunomodulatory effect of tumor necrosis factor. Biotherapy 1991;3:127-33.
40. Standiford TJ, Wilkowski JM, Sisson SH. Intrapulmonary tumor necrosis factor gene therapy increases bacterial clearance ans survival in murine gram-negative pneumonia. Hum Gene Ther 1999;10:899-909.
41. Schwarzenberger P, La Russa V, Millar A. IL-17 stimulates granulopoiesis in mice: use of an alternate, novel gene therapy-derived method for in vivo evaluation of citokines. J Immunol 1998;161:6383-9.
42. Javanovic DV, Di Battista JA, Martel-Pelletier J. IL-17 stimulates the production and expression of proinflamatory cytokines, IL-beta and TNF-alpha, by human macrophages. J Immunol 1998;160:2347-52.
43. Hotchkiss RS, Swanson PE, Freeman BD, Tinsley KW, Cobb JP, Matuschak GM. Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit Care Med 1999;27:1230-51.
44. Fukuzuka K, Edwars CK, Clare-Salzler M, Copeland EM, Moldawer LL, Mozingo DW. Glucocorticoid and Fas ligand induced mucosal lymphocyte apoptosis after burn injury. J Trauma 2000;49:710-6.
45. Oberholzer C, Oberholzer A, Bahjat FR, Minter RM, Tannahill CL, Abouhamz A. Targeted adenovirus-induced expresion of IL-10 decreases thymic apoptosis and improves survival in murine sepsis. Proc Natl Acad Sci USA 2001;98:11503-8.
46. Cohen SB, Crawley JB, Kahan MC, Feldmann M, Foxwell BM. Interleukin-10 rescues T cells from apoptotic cell death: association with an upregulation of Bcl-2. Immunology 1997;9:1-5.
47. Akhter SA, Skaer CA, Kypson AP, McDonald PH, Peppel KC, Glower DD. Restoration of beta-adrenergic signaling in failing cardiac ventricular myocytes via adenoviral-mediated gene transfer. Proc Natl Acad Sci USA 1997;94:12100-5.
48. Chinnaiyan AM, Huber-Lang M, Kumar-Sinha C, Barrette TR, Shankar-Sinha S, Sarma VJ. Molecular signatures of sepsis. Am J Pathol 2001;159:1199-209.